Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd has applied to the ASX for quotation of new ordinary fully paid shares following the conversion of options or other convertible securities. The application covers a total of 2,159,719 shares issued across three dates in April and May 2026, signaling incremental expansion of the company’s quoted equity base and potential dilution for existing shareholders.
The newly issued shares, once quoted, will increase the freely tradable float of 4DMedical on the Australian market. This modest capital expansion may provide additional liquidity in 4DX stock and reflects continued utilisation of equity-based instruments as part of the company’s financing and incentive structures.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$5.90 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is an Australian-listed company in the medical technology sector, trading on the ASX under the code 4DX. The company issues ordinary fully paid shares that are quoted on the Australian Securities Exchange, reflecting ongoing capital management and participation by holders of options or other convertible securities.
Average Trading Volume: 7,331,216
Technical Sentiment Signal: Buy
Current Market Cap: A$2.5B
Learn more about 4DX stock on TipRanks’ Stock Analysis page.